Doug Schenkel
Stock Analyst at Wolfe Research
(2.83)
# 1,539
Out of 5,182 analysts
61
Total ratings
50%
Success rate
32.17%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $36.26 | +65.47% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $300.73 | +59.61% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $83.09 | -9.74% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $18.44 | +73.54% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $51.10 | +17.42% | 1 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $59.15 | +1.44% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $16.21 | +72.73% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $292.13 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $117.43 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $3.56 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $178.98 | +59.24% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $114.87 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $34.02 | +44.18% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $21.37 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $126.92 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $470.22 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.84 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $85.18 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.58 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $7.86 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $200.17 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.00 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $4.86 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.98 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.74 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.93 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $16.65 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.82 | +538.30% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $18.63 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $182.87 | -50.78% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.34 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $139.29 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $59.32 | -73.03% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $36.26
Upside: +65.47%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $300.73
Upside: +59.61%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $83.09
Upside: -9.74%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $18.44
Upside: +73.54%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $51.10
Upside: +17.42%
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $59.15
Upside: +1.44%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $16.21
Upside: +72.73%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $292.13
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $117.43
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.56
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $178.98
Upside: +59.24%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $114.87
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $34.02
Upside: +44.18%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $21.37
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $126.92
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $470.22
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $4.84
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $85.18
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.58
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $7.86
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $200.17
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.00
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $4.86
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.98
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.74
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.93
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $16.65
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.82
Upside: +538.30%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $18.63
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $182.87
Upside: -50.78%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $3.34
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $139.29
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $59.32
Upside: -73.03%